Pages that link to "Q37132395"

The following pages link to Genome-wide association study for biomarker identification of Rapamycin and Everolimus using a lymphoblastoid cell line system (Q37132395):

Displaying 10 items.

• In vitro human cell line models to predict clinical response to anticancer drugs (Q27000665) (← links)
• The impact of microRNA-mediated PI3K/AKT signaling on epithelial-mesenchymal transition and cancer stemness in endometrial cancer (Q34091442) (← links)
• Identification of genetic variants or genes that are associated with Homoharringtonine (HHT) response through a genome-wide association study in human lymphoblastoid cell lines (LCLs) (Q34937030) (← links)
• Genome-wide association studies in Africans and African Americans: expanding the framework of the genomics of human traits and disease (Q35565624) (← links)
• Genome-wide association analysis identified splicing single nucleotide polymorphism in CFLAR predictive of triptolide chemo-sensitivity (Q35677567) (← links)
• Genotype-based clinical trials in cardiovascular disease (Q36393911) (← links)
• Computational discovery of transcription factors associated with drug response (Q36844885) (← links)
• Metformin pharmacogenomics: a genome-wide association study to identify genetic and epigenetic biomarkers involved in metformin anticancer response using human lymphoblastoid cell lines (Q38973866) (← links)
• Sirolimus Therapy Is Associated with Elevation in Circulating PCSK9 Levels in Cardiac Transplant Patients (Q49228787) (← links)
• High miR-100 expression is associated with aggressive features and modulates TORC1 complex activation in lung carcinoids. (Q55262767) (← links)